Fierce Pharma’s #FierceMadness drug name tournament highlights creativity and excellence in pharmaceutical naming. As the leader in pharmaceutical brand name development, Brand Institute played a significant role in the names participting in this year’s tournament. Here’s a breakdown of our involvement across the rounds:
Round 1: BI Partnered on 47 of 64 brand names, making up 73.4%
Round 2: BI Partnered on 24 of 32 names, with a participation rate of 75%
Sweet 16: BI Partnered on 14 of 16 names, reaching 87.5%
Elite 8: BI Partnered on 7 of 8 names, maintaining an 87.5% rate
Final 4: BI Partnered on 3 of 4 names, holding at 75%
Championship: BI proudly partnered on the brand name development for this year’s winner, Wainua
FierceMadness Final Bracket
Courtesy of Fierce Pharma
Impact Beyond Numbers
While these figures demonstrate our extensive involvement, they also reflect our commitment to quality and strategic naming in the pharmaceutical industry. Each name we work on is chosen to convey the key product concepts, patient benefits, and desired emotions/associations.
Looking Ahead
Our performance in the #FierceMadness tournament is a point of pride, but it’s also a stepping stone in our company’s journey. It reflects our dedication to excellence in pharmaceutical naming and our commitment to supporting patient safety through the development of pharmaceutical names that can be safely prescribed.
We’re grateful to our partners and clients for their trust in us. Together, we’ll continue to set standards in pharmaceutical branding and naming, ensuring each name we create stands out for its clarity, impact, and potential to benefit patients worldwide.
